FMR LLC - CATALYST PHARMACEUTICALS INC ownership

CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 254 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.

Quarter-by-quarter ownership
FMR LLC ownership history of CATALYST PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$362,748
-63.0%
31,031
-57.4%
0.00%
Q2 2023$979,288
+86.4%
72,864
+129.9%
0.00%
Q1 2023$525,430
+81.7%
31,690
+103.9%
0.00%
Q4 2022$289,116
-46.9%
15,544
-63.4%
0.00%
Q3 2022$544,000
+1713.3%
42,449
+906.4%
0.00%
Q2 2022$30,000
+7.1%
4,218
+24.2%
0.00%
Q1 2022$28,000
+100.0%
3,396
+68.2%
0.00%
Q4 2021$14,000
+16.7%
2,019
-16.5%
0.00%
Q3 2021$12,000
+71.4%
2,419
+109.8%
0.00%
Q2 2021$7,000
-12.5%
1,153
-35.9%
0.00%
Q1 2021$8,000
+33.3%
1,8000.0%0.00%
Q4 2020$6,000
+20.0%
1,8000.0%0.00%
Q3 2020$5,000
+25.0%
1,800
+150.7%
0.00%
Q2 2020$4,000
+300.0%
718
+402.1%
0.00%
Q1 2020$1,0000.0%143
-29.6%
0.00%
Q4 2019$1,0000.0%2030.0%0.00%
Q3 2019$1,000
-50.0%
203
-62.8%
0.00%
Q2 2019$2,000
-99.8%
546
-99.8%
0.00%
Q4 2017$1,173,000
+55.2%
300,0000.0%0.00%
Q3 2017$756,000
-8.7%
300,0000.0%0.00%
Q2 2017$828,000300,0000.00%
Other shareholders
CATALYST PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
TANAKA CAPITAL MANAGEMENT INC 208,189$1,726,0003.48%
FRIESS ASSOCIATES LLC 571,940$4,741,0002.53%
GABLES CAPITAL MANAGEMENT INC. 438,764$3,637,0002.28%
Prairiewood Capital, LLC 258,073$2,139,0001.50%
Quantedge Capital Pte Ltd 597,300$4,952,0001.46%
ARMISTICE CAPITAL, LLC 8,372,000$69,404,0001.34%
SummerHaven Investment Management, LLC 158,473$1,314,0000.74%
Capital Impact Advisors, LLC 99,322$823,0000.60%
EAM Investors, LLC 365,415$3,029,0000.56%
GLOBEFLEX CAPITAL L P 304,515$2,524,0000.51%
View complete list of CATALYST PHARMACEUTICALS INC shareholders